Favipiravir has been developed as an anti-influenza drug and licensed as an anti-influenza
drug in Japan. Additionally, favipiravir is being stockpiled for 2 million people as a …

With the constant threat of emergence of a novel influenza virus pandemic, there must be
continued evaluation of the molecular mechanisms that contribute to virulence. Although the …

Influenza A virus (IAV) is the sole cause of the unpredictable influenza pandemics and
deadly zoonotic outbreaks and constitutes at least half of the cause of regular annual …

Global analysis of the susceptibility of influenza viruses to neuraminidase (NA) inhibitors
(NAIs) and the polymerase acidic (PA) inhibitor (PAI) baloxavir was conducted by five World …

Influenza is an acute respiratory disease in mammals and domestic poultry that emerges
from zoonotic reservoirs in aquatic birds and bats. Although influenza viruses are among the …

This report updates previous recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and …

This report updates the 2009 recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and …

Considerable progress has been made toward understanding the structural basis of the
interaction of the two major surface glycoproteins of influenza A virus with their common …

Please cite this paper as: McKimm‐Breschkin (2012) Influenza neuraminidase inhibitors:
Antiviral action and mechanisms of resistance. Influenza and Other Respiratory Viruses 7 …

In addition to immunization programs, antiviral agents can play a major role for the control of
seasonal influenza epidemics and may also provide prophylactic and therapeutic benefits …